Status:
COMPLETED
Secondary Lactose Intolerance Due to Chronic Norovirus Infection
Lead Sponsor:
University of Zurich
Conditions:
Chronic Diarrhea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to determine the prevalence of secondary lactose intolerance in renal transplant recipients (RTR) with chronic norovirus infection. In the investigators cohort of 1000 ...
Detailed Description
In the investigators cohort of 1000 renal transplant recipients (RTRs) in the University Hospital of Zurich, the investigators are currently aware of 10 patients with chronic norovirus infection, whic...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Renal transplant recipient (RTR) with proven diagnosis of chronic norovirus infection, whereas chronic virus shedding is defined as more than two polymerase chain reaction (PCR) positive samples in an interval of at least one month (case group) or chronic diarrhoea defined as more than three bowel movements per day since more than four weeks (control group).
- Exclusion criteria:
- Missing informed consent.
- Primary lactose intolerance.
- Concomitant intestinal infection (other than norovirus).
- Subjects with galactosemia or patients requiring a low galactose diet.
- Age \< 18 years.
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01840891
Start Date
April 1 2013
End Date
December 1 2015
Last Update
December 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Division of Internal Medicine
Zurich, Canton of Zurich, Switzerland, 8091